Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion type Assertion NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_head.
- NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion wasGeneratedBy ECO_0000203 NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_provenance.
- NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion wasDerivedFrom befree-20150227 NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_provenance.
- NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion SIO_000772 22343475 NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_provenance.
- NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion evidence source_evidence_literature NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_provenance.
- NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_assertion description "[Stable vector control and MOR1 overexpressing human bronchioloalveolar carcinoma cells were evaluated using immunoblot analysis, proliferation and transendothelial extravasation assays with or without Akt inhibitor, mTOR inhibitor (temsirolimus), or the peripheral MOR antagonist, methylnaltrexone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549932.RAbBva-FEnTkYDZppuwkpv7L8qNidzFa8LaL5E6YPaf14130_provenance.